What question did this study set out to answer?

This research aims to evaluate the relationship between DLK1 expression and clinical outcomes in hepatocellular carcinoma (HCC).

January 25, 2026Journal of the Formosan Medical Association0 citationsOpen Access

View Full Paper

Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma

KHKuan-Fu HuangChang Gung University TCTian-Huei Chu CHChao‐Hung HungChang Gung University

Key Points

This research aims to evaluate the relationship between DLK1 expression and clinical outcomes in hepatocellular carcinoma (HCC).
Analyzed DLK1 expression levels in HCC patients
Correlated DLK1 levels with clinical factors such as BCLC stages and tumor size
Assessed prognosis post-surgical resection.
Elevated DLK1 expression is associated with advanced BCLC stages in HCC
Higher DLK1 levels correlate with larger tumor sizes
Patients with increased DLK1 expression exhibit poorer prognosis after resection.

Abstract

Our findings suggest that elevated DLK1 expression in HCC is linked to advanced BCLC stages, big tumor sizes and poor prognosis in HCC patients after surgical resection. DLK1 seems to serve as a valuable biomarker and may be a candidate for therapeutic targeting of HCC pending further validation.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma

Key Points

Abstract

Cite This Study

Also Consider

Also Consider